• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

SB-505124 hydrochloride

CAS No. 356559-13-2

SB-505124 hydrochloride ( —— )

产品货号. M33750 CAS No. 356559-13-2

SB-505124 hydrochloride 是一种选择性的?TGF-β Receptor type I receptor (ALK4,ALK5,ALK7) 抑制剂,对 LK4,ALK5 的?IC50 值分别为 129 nM 和 47 nM,对 ALK1,2,3 或 6 无作用。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥548 有现货
10MG ¥872 有现货
25MG ¥1423 有现货
50MG ¥2120 有现货
100MG ¥3051 有现货
500MG ¥6957 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    SB-505124 hydrochloride
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    SB-505124 hydrochloride 是一种选择性的?TGF-β Receptor type I receptor (ALK4,ALK5,ALK7) 抑制剂,对 LK4,ALK5 的?IC50 值分别为 129 nM 和 47 nM,对 ALK1,2,3 或 6 无作用。
  • 产品描述
    SB-505124 hydrochloride is a selective inhibitor of?TGF-β Receptor type I receptor (ALK4, ALK5, ALK7), with?IC50s?of 129 nM and 47 nM for?ALK4, ALK5, respectively, but it does not inhibit ALK1, 2, 3, or 6.
  • 体外实验
    SB-505124 demonstrates no toxicity to renal epithelial A498 cells at concentrations up to 100 μM for 48 h. 505124 inhibits the closely related ALK4 with an IC50 value of 129±11 nM (about 2.5-fold less sensitive than ALK5) but does not inhibit ALK2 at concentrations up to 10 μM. SB-505124 (1 μM) inhibits the TGF-β-induced phosphorylation of Smad2 in all three of these cell lines in a concentration-dependent fashion. SB-505124 (1 or 5 μM) potently inhibits TGF-β-induced activation of JNK/SAP, extracellular signal-regulated kinase 1/2, and p38 despite the different patterns of activation in these cells. SB-505124 (10 μM) impairs Smad2 phosphorylation and CTGF and α-SMA expression in vitro. SB-505124 susspresses CTGF and α-SMA observed by immunofluorescence. Cell outgrowth from explants dissected from eyes to which SB-505124 is applied during GFS is robust while outgrowth is poor from those treated with MMC.
  • 体内实验
    SB-505124 (5 mg/kg; i.p.) alone has no effect in C57Bl6 mice with A549 xenografts, but administration of SB-505124 with a single dose of Carboplatin (60 mg/kg) results in durable responses without the need for maintenance therapy in five animals.Animal Model:C57Bl6 mice with A549 xenografts Dosage:5 mg/kg Administration:I.p.; daily Result:Had no effect alone, but administration with a single dose of carboplatin (60 mg/kg) resulted in durable responses without the need for maintenance therapy in five animals.
  • 同义词
    ——
  • 通路
    Angiogenesis
  • 靶点
    ALK
  • 受体
    ALK
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    356559-13-2
  • 分子量
    371.86
  • 分子式
    C20H22ClN3O2
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?Methanol 中的溶解度 : 125 mg/mL (336.15 mM; 超声助溶) DMSO 中的溶解度 : 50 mg/mL (134.46 mM; 超声助溶 (<60°C)
  • SMILES
    Cl.N=1C(=CC=CC1C)C=2N=C(NC2C=3C=CC=4OCOC4C3)C(C)(C)C
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. DaCosta Byfield S, et al. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2004 Mar;65(3):744-52.?
产品手册
关联产品
  • INCB-000928

    Zilurgisertib (INCB-000928; NBU-928) 是一种选择性的 ALK 2 抑制剂,用于研究癌症等疾病。

  • Blu-782

    Blu-782 是一种激活素受体样激酶 2 (ALK2) 抑制剂(IC50 <10 nM)。

  • Zotizalkib

    Zotizalkib (TPX-0131) 是一种有效、选择性、CNS 渗透性和口服活性的野生型 ALK 抑制剂 (IC50 为 1.4 nM) 和 ALK 抗性突变,例如 G1202R (IC50 为 0.3 nM)、L1196M (IC50 为 0.3 nM)。Zotizalkib 具有很强的抗肿瘤活性。